AGP Limited (PSX:AGP)

Market Cap	53.12B
Revenue (ttm)	23.45B
Net Income (ttm)	2.06B
Shares Out	280.00M
EPS (ttm)	7.38
PE Ratio	25.70
Forward PE	15.59
Dividend	2.50 (1.32%)
Ex-Dividend Date	n/a

Volume	7,227,746
Average Volume	532,911
Open	189.72
Previous Close	172.47
Day's Range	185.25 - 189.72
52-Week Range	68.50 - 194.89
Beta	0.53
RSI	69.37
Earnings Date	Feb 14, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, a...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 1,574
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2023, AGP Limited's revenue was 18.74 billion, an increase of 29.63% compared to the previous year's 14.46 billion. Earnings were 1.57 billion, a decrease of -0.31%.